Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01412541 · ClinicalTrials.gov registry record · NA
Moxy Drug Coated Balloon vs. Standard Balloon Angioplasty for the Treatment of Femoropopliteal Arteries
A NA study, sponsored by C. R. Bard.
- Completed
- Registry status
- NA
- Development phase
- 532
- Enrollment target
NCT01412541 is a NA study that has completed, run by C. R. Bard. The registered enrollment target is 532 participants.
The verdict
NCT01412541, a NA study, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- NA
- Development phase
- 532 participants
- Enrollment target
Study Summary
The purpose of the study is to demonstrate the superior efficacy and non-inferior safety of the Moxy Drug Coated Balloon by direct comparison to standard percutaneous transluminal angioplasty (PTA) catheter for treatment of stenosis of the femoropopliteal arteries.
Interventions
- PROCEDURE Standard Uncoated Angioplasty Balloon
- DEVICE Moxy Drug Coated Balloon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 532 participants |
| Start Date | 2011-07 |
| Est. Completion | 2018-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01412541
The ClinicalTrials.gov registry entry for NCT01412541 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 532 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Uncoated Angioplasty Balloon is the first listed.
NCT01412541 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01412541 about?
NCT01412541 is a clinical study titled "Moxy Drug Coated Balloon vs. Standard Balloon Angioplasty for the Treatment of Femoropopliteal Arteries". The purpose of the study is to demonstrate the superior efficacy and non-inferior safety of the Moxy Drug Coated Balloon by direct comparison to standard percutaneous transluminal angioplasty (PTA) catheter for treatment of stenosis of the femoropopliteal arteries.
What is the current status of trial NCT01412541?
This trial is currently completed. It is a NA study. The enrollment target is 532 participants. The study started on 2011-07. Estimated completion is 2018-12.
What interventions are being tested in trial NCT01412541?
The interventions under investigation include: Standard Uncoated Angioplasty Balloon (PROCEDURE), Moxy Drug Coated Balloon (DEVICE).
Who is sponsoring clinical trial NCT01412541?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.